Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 124

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 124
---
 | not reorganize, amalgamate, combine or merge the Company or the Subsidiary with any other person; |

| (k) | not create any Subsidiary; |

| (l) | not acquire or commit to acquire any assets or group of related assets (through one or more related or 
 unrelated acquisitions);                                                                               |

| (m) | not incur, or commit to, capital expenditures; |

| (n) | except (1) in connection with the Discontinuance, (2) for any (x) obsolete, damaged or destroyed                                                                                                                                               
 asset, (y) return of leased assets at the end of the lease term, or (z) transfer of assets between the Company and the Subsidiary, (3) as required pursuant to the terms of any Material Contract in effect on the date of the Agreement,      
 or (4) in connection with any Permitted Disposition, not sell, lease, option, encumber or otherwise dispose of, or commit to sell, lease, option, encumber or otherwise dispose of, any assets or group of related assets (through one or more 
 related or unrelated transactions), or transfer any interest in any of the Subsidiary to a third party;                                                                                                                                        |

| (o) | (1) not incur or commit to incur any indebtedness for borrowed money, except for the borrowing of working 
 capital in connection with the Discontinuance or issue any debt securities, (2) not incur or              |

74

| commit to incur, or guarantee, endorse or otherwise become responsible for, any other material liability, obligation or indemnity or the obligation of any person other than the Subsidiary, or 
 (3) not make any loans or advances to any person other than the Subsidiary;                                                                                                                     |

| (p) | not make any material changes to existing accounting methods, principles, practices or policies or internal 
 controls other than as required by applicable Law or by GAAP;                                               |

| (r) | not engage in any transaction with any related parties other than (i) with the Company and its Subsidiary 
 in connection with the Discontinuance or (ii) in respect of a Permitted Disposition;                      |

| (s) | not commence or settle or assign any rights relating to or any interest in any litigation, proceeding, claim,                                
 action, assessment or investigation that is material to the Company and involving the Company or its Subsidi